Search

Johnson Matthey Completes Sale of Research Chemicals (Alfa Aesar) Business to Thermo Fisher Scientific Inc.

This completes the transaction which was first announced on 25th June 2015

Q1 Trading Update 2015/16

Johnson Matthey today provides its first quarter trading update. Unless otherwise stated, figures quoted are for the quarter ended 30th June 2015

Johnson Matthey Agrees Sale of Research Chemicals Business (Alfa Aesar) for £256 million

Johnson Matthey announces that it has agreed to divest its Alfa Aesar Research Chemicals business to Thermo Fisher Scientific Inc., the world leader in serving science, for £256 million

JM wins grant from Innovate UK to develop HTX sensor wire

News: Johnson Matthey was awarded a grant in the ‘Analysis for Innovators’ (A4I) competition to develop its HTX wire - one of the biggest innovations in the field of precious metal thermocouples.

USA BioEnergy secures JM and Honeywell technologies for new SAF facility in Texas, USA

News

Reclassification of Catalyst Technologies and pre-close trading update

News

Half year results for the six months ended 30th September 2025

Strong 1H performance whilst delivering a leaner, more focused and cash generative JM

Appointment of Chief Financial Officer and Chief Operating Officer

The Company is pleased to announce the appointment of Alastair Judge as Chief Financial Officer and Executive Director, effective from 1st January 2026.

Johnson Matthey officially opens first hydrogen internal combustion engine facility in Gothenburg